These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23308245)

  • 1. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
    Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
    PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
    Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
    Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
    Frömberg A; Rabe M; Aigner A
    Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion.
    Mao L; Yang C; Wang J; Li W; Wen R; Chen J; Zheng J
    J Transl Med; 2013 May; 11():111. PubMed ID: 23642278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic virus carrying shRNA targeting SATB1 inhibits prostate cancer growth and metastasis.
    Mao LJ; Zhang J; Liu N; Fan L; Yang DR; Xue BX; Shan YX; Zheng JN
    Tumour Biol; 2015 Nov; 36(11):9073-81. PubMed ID: 26084613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
    Jin Y; Cui Z; Li X; Jin X; Peng J
    Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of cellular and molecular antitumor effects upon inhibition of SATB1 in glioblastoma cells.
    Frömberg A; Rabe M; Oppermann H; Gaunitz F; Aigner A
    BMC Cancer; 2017 Jan; 17(1):3. PubMed ID: 28049521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
    Zhou D; Ye C; Pan Z; Deng Y
    Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
    [No Abstract]   [Full Text] [Related]  

  • 9. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer.
    Sun L; Liu L; Yang J; Li H; Zhang C
    J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer.
    Fang XF; Hou ZB; Dai XZ; Chen C; Ge J; Shen H; Li XF; Yu LK; Yuan Y
    World J Gastroenterol; 2013 Apr; 19(15):2331-9. PubMed ID: 23613626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
    Murali AK; Norris JS
    J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATM suppresses SATB1-induced malignant progression in breast epithelial cells.
    Ordinario E; Han HJ; Furuta S; Heiser LM; Jakkula LR; Rodier F; Spellman PT; Campisi J; Gray JW; Bissell MJ; Kohwi Y; Kohwi-Shigematsu T
    PLoS One; 2012; 7(12):e51786. PubMed ID: 23251624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
    J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
    Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
    Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of SATB1 promotes the growth and metastasis of colorectal cancer.
    Zhang Y; Tian X; Ji H; Guan X; Xu W; Dong B; Zhao M; Wei M; Ye C; Sun Y; Yuan X; Yang C; Hao C
    PLoS One; 2014; 9(6):e100413. PubMed ID: 24971456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
    Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
    PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer.
    Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK
    Cells; 2024 Jun; 13(11):. PubMed ID: 38891096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
    Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
    Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.